Literature DB >> 16306475

Looking back: rheumatoid arthritis--aetiology, occurrence and mortality.

D P M Symmons1.   

Abstract

Kellgren and Lawrence performed the first studies of the incidence and prevalence of rheumatoid arthritis (RA) in the UK. These have since been updated in Norfolk. The current annual incidence is 36/100,0000 in women and 14/100,000 in men. The prevalence is 0.8% of the adult population. The incidence, prevalence and mortality of RA have fallen in women in the last 50 yr. Excess mortality is predominantly due to cardiovascular disease. Risk factors for the development of RA include obesity, smoking, high red meat consumption, a previous blood transfusion and an adverse pregnancy outcome. Protective factors include the oral contraceptive pill and adequate fruit intake.

Entities:  

Mesh:

Year:  2005        PMID: 16306475     DOI: 10.1093/rheumatology/kei055

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  10 in total

1.  Reduced telomere length in rheumatoid arthritis is independent of disease activity and duration.

Authors:  Sophia E Steer; Frances M K Williams; Bernet Kato; Jeffry P Gardner; Paul J Norman; Margaret A Hall; Masayuki Kimura; Robert Vaughan; Abraham Aviv; Tim D Spector
Journal:  Ann Rheum Dis       Date:  2006-11-17       Impact factor: 19.103

2.  Cost-effective analysis of disease-modifying anti-rheumatic drugs in rheumatoid arthritis.

Authors:  Ashit Syngle; Sudeep Kaur; Inderjeet Verma; Tanya Syngle; Vijaita Syngle
Journal:  Clin Rheumatol       Date:  2017-06-21       Impact factor: 2.980

3.  Power of national economy, disease control and employment status in patients with RA-an analytical multi-site ecological study.

Authors:  Herwig Pieringer; Rudolf Puchner; Erich Pohanka; Kathrin Danninger
Journal:  Clin Rheumatol       Date:  2015-03-26       Impact factor: 2.980

4.  High Efficacy Combined Microneedles Array with Methotrexate Nanocrystals for Effective Anti-Rheumatoid Arthritis.

Authors:  Fang Wei; Qiuyue Wang; Hang Liu; Xuejing Yang; Wenyu Cao; Weiman Zhao; Yingying Li; Lijie Zheng; Tao Ma; Qingqing Wang
Journal:  Int J Nanomedicine       Date:  2022-05-24

Review 5.  The importance of rheumatology biologic registries in Latin America.

Authors:  Maria de la Vega; Hellen M da Silveira de Carvalho; Lucio Ventura Ríos; Maria V Goycochea Robles; Gustavo C Casado
Journal:  Rheumatol Int       Date:  2012-12-23       Impact factor: 2.631

6.  [Medical treatment of rheumatoid arthritis in 2014 : Current data from the German Collaborative Arthritis Centers].

Authors:  K Albrecht; D Huscher; T Eidner; S Kleinert; S Späthling-Mestekemper; S Bischoff; A Zink
Journal:  Z Rheumatol       Date:  2017-02       Impact factor: 1.372

7.  Biomarkers of subclinical atherosclerosis in patients with autoimmune disorders.

Authors:  Elisabetta Profumo; Manuela Di Franco; Brigitta Buttari; Roberta Masella; Carmelina Filesi; Maria Elena Tosti; Rossana Scrivo; Antongiulio Scarno; Antonio Spadaro; Luciano Saso; Rachele Riganò
Journal:  Mediators Inflamm       Date:  2012-02-22       Impact factor: 4.711

8.  Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2.

Authors:  Evangelia S Lourida; Athanasios N Georgiadis; Eleni C Papavasiliou; Athanasios I Papathanasiou; Alexandros A Drosos; Alexandros D Tselepis
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

9.  Improving patient flow of people with rheumatoid arthritis has the potential to simultaneously improve health outcomes and reduce direct costs.

Authors:  R Puchner; R Hochreiter; H Pieringer; A Vavrovsky
Journal:  BMC Musculoskelet Disord       Date:  2017-01-07       Impact factor: 2.362

10.  Body Mass Index and Risk of Rheumatoid Arthritis: A Meta-Analysis of Observational Studies.

Authors:  Jian Feng; Qi Chen; Feifei Yu; Zhiyong Wang; Shuqi Chen; Zhichao Jin; Qing Cai; Yu Liu; Jia He
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.